G
Gilbert Greub
Researcher at University of Lausanne
Publications - 552
Citations - 22123
Gilbert Greub is an academic researcher from University of Lausanne. The author has contributed to research in topics: Parachlamydia acanthamoebae & Chlamydiales. The author has an hindex of 69, co-authored 516 publications receiving 19144 citations. Previous affiliations of Gilbert Greub include Centre national de la recherche scientifique & University of Basel.
Papers
More filters
Journal ArticleDOI
Microorganisms Resistant to Free-Living Amoebae
Gilbert Greub,Didier Raoult +1 more
TL;DR: Free-living amoebae represent an important reservoir of ARB and may, while encysted, protect the internalized bacteria from chlorine and other biocides, and represent a useful tool for the culture of some intracellular bacteria and new bacterial species that might be potential emerging pathogens.
Journal ArticleDOI
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.
Gilbert Greub,Bruno Ledergerber,Manuel Battegay,P. J. Grob,Luc Perrin,Hansjakob Furrer,Philippe Bürgisser,Peter Erb,Katia Boggian,Jean-Claude Piffaretti,Bernard Hirschel,Pascal Janin,Patrick Francioli,Markus Flepp,Amalio Telenti +14 more
TL;DR: Hematitis C virus and active intravenous drug use could be important factors in the morbidity and mortality among HIV-1-infected patients, possibly through impaired CD4-cell recovery in HCV seropositive patients receiving potent antiretroviral therapy.
Journal ArticleDOI
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.
Catia Marzolini,Amalio Telenti,Laurent A. Decosterd,Gilbert Greub,Jérôme Biollaz,Thierry Buclin +5 more
TL;DR: Treatment failure and CNS side-effects are associated with low and high efavirenz plasma levels, respectively, which strongly argues for dose adjustment on the basis of therapeutic drug monitoring to optimize treatment.
Journal ArticleDOI
Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology
TL;DR: MALDI-TOF MS has been used successfully for microbial typing and identification at the subspecies level, demonstrating that this technology is a potential efficient tool for epidemiological studies and for taxonomical classification.
Journal ArticleDOI
Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Bacterial Strains Routinely Isolated in a Clinical Microbiology Laboratory
TL;DR: In this article, the authors compared MALDI-TOF MS to the conventional phenotypic method for the identification of routine isolates and concluded that MAL DI-to-FMS is a fast and reliable technique which has the potential to replace conventional phenotype identification for most bacterial strains routinely isolated in clinical microbiology laboratories.